From: Functional and genetic analysis of the colon cancer network
chr | locus | start | Size | edges | pvalue | gcc | census | term |
---|---|---|---|---|---|---|---|---|
chr8 | q24.3 | 145000001 | 35 | 52 | 3.6e-86 | 29 | RECQL4 | Â |
chr8 | q24.3 | 145500001 | 31 | 37 | 3.3e-59 | 24 | RECQL4 | Â |
chr6 | p22.2/p22.1 | 26000001 | 45 | 40 | 3.5e-52 | 23 | Â | nucleosome assembly (9) |
chr6 | p22.2 | 25500001 | 46 | 40 | 2.1e-51 | 24 | Â | nucleosome assembly (9) |
chrX | q28 | 153000001 | 37 | 33 | 1.2e-45 | 18 | Â | Â |
chr19 | q13.31 | 44000001 | 35 | 31 | 1.8e-43 | 15 | Â | regulation of transcription, DNA- |
 |  |  |  |  |  |  |  | dependent (15) |
chr7 | p15.1/.2 | 27000001 | 17 | 21 | 4.4e-39 | 12 | HOXA9, HOXA11, HOXA13, JAZF1 | anterior/posterior pattern specification (9) |
chr7 | p15.2 | 26500001 | 18 | 21 | 6e-38 | 12 | HOXA9, HOXA11, HOXA13 | anterior/posterior pattern specification (9) |
chr8 | q24.3 | 144500001 | 30 | 26 | 1e-37 | 14 | Â | Â |
chr6 | p21.1 | 42500001 | 32 | 26 | 3.3e-36 | 18 | Â | meiosis (3) |
chr19 | q13.31/q13.32 | 44500001 | 28 | 24 | 2.7e-35 | 12 | BCL3, CBLC | regulation of transcription, DNA- dependent (12) |
chr17 | q12/q21.1/.2 | 37500001 | 26 | 22 | 8.4e-33 | 13 | ERBB2, | Â |
 |  |  |  |  |  |  | RARA |  |
chr17 | p13.1 | 7000001 | 56 | 32 | 3.3e-32 | 22 | TP53 | Â |
chrX | q28 | 153500001 | 30 | 22 | 5.6e-30 | 14 | MTCP1 | Â |
chr1 | q22 | 155000001 | 33 | 23 | 6.4e-30 | 20 | MUC1 | Â |
chr17 | q11.2 | 26500001 | 34 | 23 | 2.6e-29 | 17 | Â | Â |
chr8 | p11.21 | 42000001 | 16 | 16 | 3.3e-28 | 11 | HOOK3 | Â |
chr6 | p21.31/.32 | 32500001 | 34 | 22 | 1.6e-27 | 7 | DAXX | antigen processing and presentation of exogenous peptide antigen via MHC class II (6) proteasomal ubiquitin-dependent protein catabolic process (3) |
chr9 | q34.3 | 139500001 | 53 | 27 | 3.4e-26 | 15 | Â | Â |
chrX | p11.23 | 48500001 | 28 | 19 | 1.5e-25 | 14 | WAS, GATA1, TFE3 | Â |
chr17 | q21.32 | 46000001 | 26 | 18 | 7.2e-25 | 7 | Â | embryonic skeletal system development (5) |
chr16 | p13.3 | 1500001 | 47 | 24 | 2.5e-24 | 15 | TSC2 | protein ubiquitination (4) |
chr17 | q21.32/.33 | 46500001 | 27 | 18 | 3e-24 | 7 | Â | embryonic skeletal system development (5) |
chr17 | p13.1 | 6500001 | 51 | 25 | 4e-24 | 20 | Â | Â |
chr8 | q24.3 | 144000001 | 29 | 18 | 4e-23 | 7 | Â | heterocycle metabolic process (6) |
chr6 | p21.33 | 31000001 | 54 | 25 | 6.8e-23 | 13 | Â | Â |
chr6 | p21.32/.33 | 31500001 | 54 | 25 | 6.8e-23 | 14 | Â | Â |
chr19 | q13.43 | 58000001 | 40 | 21 | 9.2e-23 | 14 | Â | transcription, DNA-dependent (14) regulation of type I interferon- mediated signaling pathway (8) homophilic cell adhesion (8) cellular biosynthetic process (9) |
chr9 | p21.3 | 20500001 | 20 | 15 | 1e-22 | 8 | MLLT3 | Â |
chr5 | q31.3 | 140000001 | 52 | 24 | 3e-22 | 8 | Â | Â |
chr17 | q12 | 37000001 | 21 | 15 | 4.4e-22 | 13 | LASP1, ERBB2 | Â |
chr8 | p11.22/.23 | 37500001 | 18 | 14 | 5.2e-22 | 8 | WHSC1L1, FGFR1 | Â |
chr19 | q13.43 | 57500001 | 35 | 19 | 8.4e-22 | 10 | Â | regulation of transcription, DNA-dependent (10) |
chr17 | q25.3 | 79500001 | 46 | 22 | 1e-21 | 20 | ASPSCR1 | proteasomal ubiquitin-dependent protein catabolic process (3) |
chrX | p11.23 | 48000001 | 28 | 16 | 5.6e-20 | 10 | SSX1, WAS, GATA1, TFE3 | Â |